Thymosin β-4 is a peptide that is found to have many regenerative properties. Various animal studies have shown that when using Tβ4 in mammalian cells it led to wound healing in dermal, corneal, and cardiac cells. In addition to its wound healing properties, Tβ4 has been shown to improve cell survival, formation of blood vessels, and maturation of stem cells as well as decrease levels of inflammatory cytokines and chemokines
These claims are supported in a study conducted by Phlip and Kleinman in which they applied a topical treatment of Tβ4 to both alkali and heptanol related injuries in the eyes and the skin of rats and mice.